ID   CAL-9 [Human ovarian carcinoma]
AC   CVCL_5V15
SY   CAL 9; Centre Antoine Lacassagne-9
DR   Wikidata; Q54808415
RX   PubMed=2145926;
RX   PubMed=2440566;
CC   Doubling time: 54 hours (PubMed=2145926).
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 6
//
RX   PubMed=2145926; DOI=10.1016/0277-5379(90)90186-W;
RA   Olivier S., Formento P., Fischel J.-L., Etienne-Grimaldi M.-C.,
RA   Milano G.;
RT   "Epidermal growth factor receptor expression and suramin cytotoxicity
RT   in vitro.";
RL   Eur. J. Cancer 26:867-871(1990).
//
RX   PubMed=2440566;
RA   Gioanni J., Samson M., Zanghellini E., Mazeau C., Ettore F.,
RA   Demard F., Chauvel P., Duplay H., Schneider M., Laurent J.-C.,
RA   Lalanne C.-M.;
RT   "Characterization of a new surface epitope specific for human
RT   epithelial cells defined by a monoclonal antibody and application to
RT   tumor diagnosis.";
RL   Cancer Res. 47:4417-4424(1987).
//